Manulife (Manufacturers Life Insurance)
TXMD icon

Manulife (Manufacturers Life Insurance)’s TherapeuticsMD TXMD Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-4,042
Closed -$76.8K – 3143
2022
Q1 		$76.8K Hold
4,042
– – ﹤0.01% 2997
2021
Q4 		$72 Sell
4,042
-1,036
-20% -$31K ﹤0.01% 3077
2021
Q3 		$188K Buy
5,078
+734
+17% +$32.6K ﹤0.01% 3009
2021
Q2 		$258K Buy
4,344
+376
+9% +$22.8K ﹤0.01% 2934
2021
Q1 		$266K Buy
3,968
+618
+18% +$48.4K ﹤0.01% 2693
2020
Q4 		$203K Buy
3,350
+393
+13% +$26.8K ﹤0.01% 2765
2020
Q3 		$234K Hold
2,957
– – ﹤0.01% 2465
2020
Q2 		$174K Buy
2,957
+50
+2% +$2.91K ﹤0.01% 2564
2020
Q1 		$154K Buy
2,907
+478
+20% +$47.4K ﹤0.01% 2439
2019
Q4 		$294K Sell
2,429
-64
-3% -$9.2K ﹤0.01% 2352
2019
Q3 		$471K Sell
2,493
-59
-2% -$8.32K ﹤0.01% 2053
2019
Q2 		$332K Buy
2,552
+94
+4% +$16.9K ﹤0.01% 2301
2019
Q1 		$599K Sell
2,458
-95
-4% -$25.1K ﹤0.01% 1984
2018
Q4 		$486K Buy
2,553
+114
+5% +$27.8K ﹤0.01% 1974
2018
Q3 		$800K Sell
2,439
-103
-4% -$31.6K ﹤0.01% 1949
2018
Q2 		$793K Buy
2,542
+31
+1% +$9.47K ﹤0.01% 2040
2018
Q1 		$611K Sell
2,511
-51
-2% -$14.3K ﹤0.01% 2193
2017
Q4 		$774K Buy
2,562
+124
+5% +$34.5K ﹤0.01% 2020
2017
Q3 		$644K Sell
2,438
-34
-1% -$9.83K ﹤0.01% 2094
2017
Q2 		$651K Buy
2,472
+82
+3% +$20.5K ﹤0.01% 2095
2017
Q1 		$861K Buy
2,390
+293
+14% +$90.7K ﹤0.01% 1821
2016
Q4 		$605K Buy
2,097
+13
+0.6% +$4.03K ﹤0.01% 1985
2016
Q3 		$710K Buy
2,084
+19
+0.9% +$6.94K ﹤0.01% 1844
2016
Q2 		$878K Buy
2,065
+281
+16% +$116K ﹤0.01% 1697
2016
Q1 		$574K Buy
1,784
+77
+5% +$26.3K ﹤0.01% 1916
2015
Q4 		$885 Buy
1,707
+18
+1% +$6.64K ﹤0.01% 1688
2015
Q3 		$495 Buy
1,689
+40
+2% +$14.2K ﹤0.01% 2013
2015
Q2 		$648 Buy
1,649
+104
+7% +$36.7K ﹤0.01% 1948
2015
Q1 		$467 Buy
1,545
+139
+10% +$33.9K ﹤0.01% 2124
2014
Q4 		$313 Sell
1,406
-35
-2% -$7.22K ﹤0.01% 2319
2014
Q3 		$335 Buy
1,441
+117
+9% +$29.5K ﹤0.01% 2263
2014
Q2 		$293K Sell
1,324
-10
-0.7% -$2.23K ﹤0.01% 2437
2014
Q1 		$421 Buy
1,334
+53
+4% +$16.9K ﹤0.01% 2201
2013
Q4 		$334 Buy
1,281
+103
+9% +$22.6K ﹤0.01% 2331
2013
Q3 		$173 Sell
1,178
-81
-6% -$9.79K ﹤0.01% 2758
2013
Q2 		$190K Buy
+1,259
New +$172K ﹤0.01% 2606

Other funds holding TXMD

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s TXMD Position: Q2 2022 in Review

Manulife (Manufacturers Life Insurance) sold out of TherapeuticsMD (TXMD) in Q2 2022, closing a stake of 4,042 shares — an estimated $76.8K sold.

Manulife (Manufacturers Life Insurance) first reported a position in TXMD in Q2 2013 and held it in 36 quarters. The position peaked at $878K in Q2 2016. 53 funds tracked by Wall St. Rank hold TXMD as of Q2 2022.

  • Manulife (Manufacturers Life Insurance) reported no remaining TherapeuticsMD position as of Q2 2022 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 4,042 TherapeuticsMD shares in Q2 2022, an estimated $76.8K.
  • Manulife (Manufacturers Life Insurance) first reported a position in TherapeuticsMD in Q2 2013 and held it in 36 quarters.
  • Manulife (Manufacturers Life Insurance)'s TherapeuticsMD position peaked at $878K in Q2 2016.
  • 53 funds tracked by Wall St. Rank held TherapeuticsMD as of Q2 2022.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2022, filed 15 Aug 2022.